Fairchem Organics Ltd Q1 FY2024 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/t1u3wdoi41gsfgiv9zqpj57j.pdf

Key Takeaways


The Margin Shock: China, Compliance, and Trials

Nahoosh Jariwala: "We have to retain the market share by hook or crook and that is exactly what we are doing because it took years for us to reach a market share of 75% from 25%. Now at this stage, I do not want to lose because China is dumping and I just want to give them way to sell more. No, that's not the thing we are going head-on."

Isostearic Acid: The Margin Reset Opportunity

Rajen Jhaveri: "So, it is a double-edged sword. We want to retain our market share also, we want to make more dimer acid also so that we can get more monobasic acid and so that we can make more isostearic acid. So, it is a business decision in the interest of the company only."

Demand and Volume Dynamics


Strategy: Absorbing Pain for Future Gain

Rajen Jhaveri: "But we are looking for the better future and for the better future you need to bear some loss in one or two quarters, then only you will get this better future."

Operational Efficiency and Cost Structure


Guidance & Commitments

CommitmentSpecificsTimeline
Isostearic acid commercial revenue~₹25 crores per quarter incremental revenueStarting Q3 FY24
Isostearic acid stability testsCustomer-side stability testing completed2-3 months from now
Chinese dumping cessationDumping expected to stopMaximum two quarters
Full-year revenue target₹700 crore-plus revenues with margin stabilityRest of FY24
Q2 margin improvementMargins should be better than Q1Q2 FY24
Volume growthVolume rise in 7%-8% rangeOngoing
New raw material projectProject on track, company will be first in IndiaMay take "couple of months more"

Key Metrics

MetricQ1 FY24
Revenue from operations₹161 cr
EBITDANearly ₹12 cr
EBITDA margin7.29%
Net profit after taxApproximately ₹6 cr
Sales volume growth (QoQ)18% higher
Sales volume growth (YoY)3.2% higher
Quantity processed growth (YoY)2.8%
Material cost as a percentage of revenue80%-82%, up from 70%-72%
Domestic sales share96% of total sales
Export sales share4% of total sales
Linoleic acid and dimer acid share of total sales74%-75%
Paints and inks end-user share of total sales50%
Isostearic acid expected incremental revenue per quarter₹25 cr
Isostearic acid trials and related costs impact on EBITDA₹5 cr fall, including ₹2 cr trial loss, ₹2.5 cr June revenue impact, and ₹50 lakh legal compliance cost
REACH compliance one-time legal costApproximately ₹45 lakh